Androgenetic alopecia (Male pattern hair loss) in the united states: What treatments should primary care providers recommend?

Journal of the American Association of Nurse Practitioners

Volumn 25, Issue 8, 2013, Pages 395-401

  Chin, Evelyn Y ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

5a reductase inhibitor; Adults; Dermatology; Evidence based practice; Male; Primary care; Treatment

Indexed keywords

ALOPECIA; HUMAN; MALE; PRIMARY HEALTH CARE; UNITED STATES;

ALOPECIA; HUMANS; MALE; PRIMARY HEALTH CARE; UNITED STATES;

EID: 84927172327     PISSN: 23276886     EISSN: 23276924     Source Type: Journal    
DOI: 10.1111/1745-7599.12030     Document Type: Article

References (26)

1. Agrawal, M. (2008). Modern artificial hair implantation: A pilot study of 10 patients. Journal of Cosmetic Dermatology, 7(4), 315–323.
2. Avram, M. R., & Rogers, N. E. (2009). The use of low-level light for hair growth: Part I. Journal of Cosmetic and Laser Therapy, 11, 110–117.
3. Blumeyer, A., Tosti, A., Messenger, A., Reygagne, P., del Marmol, V., Spuls, P. I., & Blume-Peytavi, U. (2011). Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and men. Journal of the German Society of Dermatology, (Suppl 6), S1–S57. doi:10.1111/j.1610–0379.2011.07802.x
4. Cash, T. F. (2009). Attitudes, behaviors, and expectations of men seeking medical treatment for male pattern hair loss: Results of a multinational survey. Current Medical Research and Opinion, 25(7), 1811–1820. doi:10.1185/03007990903005201
5. Department of Health & Human Services, & Food and Drug Administration. (2011). HairMax LaserComb Advanced 7, Lux 9 and Professional 12: 510k Premarket Application. Section 5: 510(k) summary. Retrieved from http://www.accessdata.fda.gov/cdrhdocs/pdf10/K103368.pdf?utmcampaign=Google2&utm source=fdaSearch&utmmedium=website&utmterm=male%20pattern%20baldness&utm content=7
6. Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & GRADE Working Group. (2008). GRADE: An emerging consensus on rating quality o evidence and strength of recommendations. British Medical Journal, 336, 924–926. doi:10.1136/bmj.39489.470347.AD
7. Jones, M. C. (2008). Treatment options for androgenic alopecia. US Pharmacist, 33(8), 49–52.
8. Kaufman, K. D., Girman, C. J., Round, E. M., Johnson-Levonas, A. O., Shah, A. K., & Rotonda, J. (2008). Progression of hair loss in men with androgenetic alopecia (male pattern baldness): Long-term (5-year) controlled observational data in placebo-treated patients. European Journal of Dermatology, 18(4), 407–411.
9. Kaufman, K. D., Rotonda, J., Shah, A. K., & Meehan, A. G. (2008). Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss). European Journal of Dermatology, 18(4), 400–406.
10. Leavitt, M., Charles, G., Heyman, E., & Michaels, D. (2009). HairMax LaserComb laser phototherapy device in the treatment of male androgenetic alopecia: A randomized, double-blind, sham device-controlled, multicenter trial. Clinical Drug Investigation, 29(5), 283–292. doi:10.2165/00044011–200929050–00001
11. Lee, T. S., & Minton, T. J. (2009). An update on hair restoration therapy. Current Opinion in Otolaryngology and Head and Neck Surgery, 17(4), 287–294. doi:10.1097/MOO.0b013e32832da13b
12. Lexington International, LLC. (2013a). Hair Max LaserComb FDA clearance for males and females: A milestone in the treatment of hair loss and the promotion of hair growth. Retrieved from http://www.hairmax.com/fda-clearance
13. Lexington International, LLC. (2013b). HairMax LaserComb devices. Retrieved from http://hairmaxestore.com/buy-hairmax-lasercomb
14. Minoxidil Shop. (2013). Minoxidil buyer’s guide. Retrieved from http://www.minoxidilshop.com/buyersguide.html
15. Mounsey, A. L., & Reed, S. W. (2009). Diagnosing and treating hair loss. American Family Physician, 80(4), 356–362.
16. Norwood, O. T. (1975). Male pattern baldness: Classification and incidence. Southern Medical Journal, 68(11), 1359–1365.
17. Olsen, E. A., Whiting, D., Bergfeld, W., Miller, J., Hordinsky, M., Wanswer, R., & Kohut, B. (2007). A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men. Journal of the American Academy of Dermatology, 57(5), 767–774.
18. Olsen, E. A., Whiting, D. A., Savin, R., Rodgers, A., Johnson-Levonas, A. O., Round, E., & Kaufman, K. D. (2012). Global photographic assessment of men aged 18 to 60 years with male pattern hair loss receiving finasteride 1 mg or placebo. Journal of the American Academy of Dermatology, 67(3), 379–386. doi:10.1016/j.jaad.2011.10.027
19. Pray, W. S. (2008). Prevention and treatment of hair loss in men. US Pharmacist, 33(8), 16–20.
20. Propecia. (2012). 9 out of 10 men improved or maintained hair with Propecia. Retrieved from http://www.propecia.com/finasteride/propecia/consumer/index.jsp?WT.svl=2
21. Rathnayake, D., & Sinclair, R. (2010). Male androgenetic alopecia. Expert Opinion on Pharmacotherapy, 11(8), 1295–1304. doi:10.1517/14656561003752730
22. Rossi, A., Cantisani, C., Scarno, M., Trucchia, A., Fortuna, M. C., & Calvieri, S. (2011). Finasteride, 1 mg daily administration on male androgenetic alopecia in different age groups: 10-year follow-up. Dermatologic Therapy, 24(4), 455–461. doi:10.1111/j.1529–8019.2011.01441.x
23. Rushton, D. H., & Gilkes, J. J. (2011). Delaying treatment in male-pattern hair loss affects the therapeutic response. Clinical and Experimental Dermatology, 36(2), 204–225. doi:10.1111/j.1365–2230.2010.03907.x
24. Stough, D. (2007). Dutasteride improves male pattern hair loss in a randomized study in identical twins. Journal of Cosmetic Dermatology, 6, 9–13.
25. Tsuboi, R., Itami, S., Inui, S., Ueki, R., Katsuoka, K., Kurata, S., & Guidelines Planning Committee for the Management of Androgenetic Alopecia (2012). Guidelines for the management of androgenetic alopecia (2010). Journal of Dermatology, 39, 113–120. doi:10.1111/j.1346–8138.2011.01361.x
26. Zimber, M. P., Ziering, C., Zeigler, F., Hubka, M., Mansbridge, J. N., Baumgartner, M., & Naughton, G. K. (2011). Hair regrowth following a wnt- and follistatin-containing treatment: Safety and efficacy in a first-in-man phase 1 clinical trial. Journal of Drugs in Dermatology, 10(11), 1308–1312.